Intrinsic Value of S&P & Nasdaq Contact Us

Procaps Group S.A. PROC NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • LU • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+890.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Procaps Group S.A. (PROC) trades at a trailing P/E of 2.4, forward P/E of 1.7. Trailing earnings yield is 41.67%, forward earnings yield 59.52%. PEG 0.04 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (2.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.04); analyst target implies upside (+890.1%); earnings yield beats bond yields (41.67%).
  • Forward P/E 1.7 (down from trailing 2.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 41.67% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 59.52% as earnings recover.
  • Analyst consensus target $10.00 (+890.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
~
GROWTH
40/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — PROC

Valuation Multiples
P/E (TTM)2.4
Forward P/E1.7
PEG Ratio0.04
Forward PEG0.04
P/B Ratio0.00
P/S Ratio0.25
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.42
Forward EPS (Est.)$0.60
Book Value / Share$0.00
Revenue / Share$4.05
FCF / Share$0.00
Yields & Fair Value
Earnings Yield41.67%
Forward Earnings Yield59.52%
Dividend Yield0.00%
Analyst Target$10.00 (+890.1%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.15 $324.79M $-17.01M -5.2%
2020 $-0.09 $331.47M $-10.45M -3.2%
2021 $-1.03 $409.74M $-100.86M -24.6%
2022 $0.42 $409.92M $42.54M 10.4%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message